India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Mot 170.70 0.09
State Ba 255.60 1.67
Asian Pa 1132.50 5.74
Icici Ba 319.90 2.17
I T C Lt 286.50 0.61
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Strides Pharma Science Limited
Strides Pharma Science Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
Market Lot: 1Face Value: 10ISIN Demat: INE939A01011
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
20-Sep-2018       Strides Pharma Science gets ACCC approval for merger of Arrow and Apotex Australia IRIS
18-Sep-2018       Strides Pharma Science completes inspection for product pre-approval IRIS
05-Sep-2018       Strides Pharma arm gets nod for Potassium Cl ER tablets IRIS
22-Aug-2018       Strides receives USFDA acceptance for two key ANDAs IRIS
02-Jul-2018       Strides Shasun gets USFDA approval for Ibuprofen OTC Tablets IRIS
02-Jul-2018       Strides Shasun receives USFDA tentative approval for Milnacipran Hydrochloride Tablets IRIS
19-Jun-2018       Strides Shasun receives USFDA nod for Ketoconazole tablets IRIS
12-Jun-2018       Strides Shasun receives nod for Oseltamivir Phosphate capsules IRIS
18-May-2018       Strides Shasun turns to loss in Jan-Mar quarter IRIS
09-May-2018       Strides and Apotex agree to merge their Australian businesses IRIS
25-Apr-2018       Strides Shasun to divest API arm to Solara for Rs 1.31 bn IRIS
12-Apr-2018       Strides Shasun receives USFDA nod for Cyproheptadine HCl tablets IRIS
02-Apr-2018       Strides Shasun gets USFDA nod for Ibuprofen Softgel capsules IRIS
14-Mar-2018       Strides Shasun receives USFDA approval for Efavirenz tablets IRIS
26-Feb-2018       Strides Shasun to launch Ranitidine OTC tablets in US IRIS
31-Jan-2018       Strides Shasun receives USFDA approval for Piroxicam capsules IRIS
31-Jan-2018       Strides Shasun gets nod for Nystatin and Triamcinolone Acetonide ointment IRIS
29-Jan-2018       Strides Shasun gets USFDA nod for Tenofovir Disoproxil Fumarate tablets IRIS
20-Dec-2017       Strides Shasun acquires controlling stake in Trinity Pharma, SA IRIS
22-Nov-2017       Strides Shasun's arm receives USFDA approval for Acetazolamide tablets IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited